Clinical Trial

Molecular Analysis of Samples From Patients With Diffuse Intrinsic Pontine Glioma and Brainstem Glioma

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 20, 2024 (before its estimated April 2025 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to prospectively collect specimens from pediatric patients with diffuse intrinsic pontine glioma or brainstem glioma, either during therapy or at autopsy, in order to characterize the molecular abnormalities of this tumor.
Protocol Amendment History 17 amendments
This ClinicalTrials.gov record has been amended 17 times since 2010-04-19; most recent amendment 2024-08-19.
Status change: Not Yet Recruiting → Recruiting 2010-05-07
Trial Details
NCT Number NCT01106794
Lead Sponsor Children's National Research Institute
Conditions Diffuse Intrinsic Pontine Glioma, Brainstem Glioma
Enrollment 100 participants
Start Date 2010-04
Primary Completion 2025-04 (estimated)
Study Completion 2030-04 (estimated)
Updated on ClinicalTrials.gov 2024-08-20